Literature DB >> 32789511

Diabetes, Weight Change, and Pancreatic Cancer Risk.

Chen Yuan1, Ana Babic1, Natalia Khalaf2,3, Jonathan A Nowak4,5, Lauren K Brais1, Douglas A Rubinson1, Kimmie Ng1, Andrew J Aguirre1, Pari V Pandharipande6, Charles S Fuchs7, Edward L Giovannucci8,9,10, Meir J Stampfer8,9,10, Michael H Rosenthal1, Chris Sander11,12, Peter Kraft8,13, Brian M Wolpin1.   

Abstract

Importance: Pancreatic cancer is the third-leading cause of cancer death in the United States; however, few high-risk groups have been identified to facilitate early diagnosis strategies. Objective: To evaluate the association of diabetes duration and recent weight change with subsequent risk of pancreatic cancer in the general population. Design, Setting, and Participants: This cohort study obtained data from female participants in the Nurses' Health Study and male participants in the Health Professionals Follow-Up Study, with repeated exposure assessments over 30 years. Incident cases of pancreatic cancer were identified from self-report or during follow-up of participant deaths. Deaths were ascertained through reports from the next of kin, the US Postal Service, or the National Death Index. Data collection was conducted from October 1, 2018, to December 31, 2018. Data analysis was performed from January 1, 2019, to June 30, 2019. Exposures: Duration of physician-diagnosed diabetes and recent weight change. Main Outcome and Measures: Hazard ratios (HRs) for subsequent development of pancreatic cancer.
Results: Of the 112 818 women (with a mean [SD] age of 59.4 [11.7] years) and 46 207 men (with a mean [SD] age of 64.7 [10.8] years) included in the analysis, 1116 incident cases of pancreatic cancers were identified. Compared with participants with no diabetes, those with recent-onset diabetes had an age-adjusted HR for pancreatic cancer of 2.97 (95% CI, 2.31-3.82) and those with long-standing diabetes had an age-adjusted HR of 2.16 (95% CI, 1.78-2.60). Compared with those with no weight loss, participants who reported a 1- to 4-lb weight loss had an age-adjusted HR for pancreatic cancer of 1.25 (95% CI, 1.03-1.52), those with a 5- to 8-lb weight loss had an age-adjusted HR of 1.33 (95% CI, 1.06-1.66), and those with more than an 8-lb weight loss had an age-adjusted HR of 1.92 (95% CI, 1.58-2.32). Participants with recent-onset diabetes accompanied by weight loss of 1 to 8 lb (91 incident cases per 100 000 person-years [95% CI, 55-151]; HR, 3.61 [95% CI, 2.14-6.10]) or more than 8 lb (164 incident cases per 100 000 person-years [95% CI, 114-238]; HR, 6.75 [95% CI, 4.55-10.00]) had a substantially increased risk for pancreatic cancer compared with those with neither exposure (16 incident cases per 100 000 person-years; 95% CI, 14-17). Incidence rates were even higher among participants with recent-onset diabetes and weight loss with a body mass index of less than 25 before weight loss (400 incident cases per 100 000 person-years) or whose weight loss was not intentional judging from increased physical activity or healthier dietary choices (334 incident cases per 100 000 person-years). Conclusions and Relevance: This study demonstrates that recent-onset diabetes accompanied by weight loss is associated with a substantially increased risk for developing pancreatic cancer. Older age, previous healthy weight, and no intentional weight loss further elevate this risk.

Entities:  

Mesh:

Year:  2020        PMID: 32789511      PMCID: PMC7426876          DOI: 10.1001/jamaoncol.2020.2948

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


  36 in total

1.  A Glimmer of Hope for Pancreatic Cancer.

Authors:  Hedy L Kindler
Journal:  N Engl J Med       Date:  2018-12-20       Impact factor: 91.245

2.  A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes.

Authors:  Ben Boursi; Brian Finkelman; Bruce J Giantonio; Kevin Haynes; Anil K Rustgi; Andrew D Rhim; Ronac Mamtani; Yu-Xiao Yang
Journal:  Gastroenterology       Date:  2016-12-05       Impact factor: 22.682

3.  Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma.

Authors:  Raghuwansh P Sah; Ayush Sharma; Sajan Nagpal; Sri Harsha Patlolla; Anil Sharma; Harika Kandlakunta; Vincent Anani; Ramcharan Singh Angom; Amrit K Kamboj; Nazir Ahmed; Sonmoon Mohapatra; Sneha Vivekanandhan; Kenneth A Philbrick; Alexander Weston; Naoki Takahashi; James Kirkland; Naureen Javeed; Aleksey Matveyenko; Michael J Levy; Debabrata Mukhopadhyay; Suresh T Chari
Journal:  Gastroenterology       Date:  2019-01-22       Impact factor: 22.682

4.  Is Screening for Pancreatic Cancer in High-Risk Individuals One Step Closer or a Fool's Errand?

Authors:  Phil A Hart; Suresh T Chari
Journal:  Clin Gastroenterol Hepatol       Date:  2018-09-27       Impact factor: 11.382

5.  Probability of pancreatic cancer following diabetes: a population-based study.

Authors:  Suresh T Chari; Cynthia L Leibson; Kari G Rabe; Jeanine Ransom; Mariza de Andrade; Gloria M Petersen
Journal:  Gastroenterology       Date:  2005-08       Impact factor: 22.682

6.  A Prospective Study to Establish a New-Onset Diabetes Cohort: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.

Authors:  Anirban Maitra; Ayush Sharma; Randall E Brand; Stephen K Van Den Eeden; William E Fisher; Phil A Hart; Steven J Hughes; Kieren J Mather; Stephen J Pandol; Walter G Park; Ziding Feng; Jose Serrano; Jo Ann S Rinaudo; Sudhir Srivastava; Suresh T Chari
Journal:  Pancreas       Date:  2018 Nov/Dec       Impact factor: 3.327

7.  Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men.

Authors:  F B Hu; M F Leitzmann; M J Stampfer; G A Colditz; W C Willett; E B Rimm
Journal:  Arch Intern Med       Date:  2001-06-25

8.  Temporal association of changes in fasting blood glucose and body mass index with diagnosis of pancreatic cancer.

Authors:  Rahul Pannala; Cynthia L Leibson; Kari G Rabe; Lawrence J Timmons; Jeanine Ransom; Mariza de Andrade; Gloria M Petersen; Suresh T Chari
Journal:  Am J Gastroenterol       Date:  2009-06-09       Impact factor: 10.864

9.  Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes.

Authors:  Ayush Sharma; Harika Kandlakunta; Sajan Jiv Singh Nagpal; Ziding Feng; William Hoos; Gloria M Petersen; Suresh T Chari
Journal:  Gastroenterology       Date:  2018-06-11       Impact factor: 22.682

10.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

View more
  16 in total

1.  ASO Author Reflections: Prediagnosis Weight Loss: Early Detection and Postoperative Prognosis Among Patients with Pancreatic Cancer.

Authors:  Jonathan J Hue; Jordan M Winter; Sarah C Markt
Journal:  Ann Surg Oncol       Date:  2021-03-25       Impact factor: 5.344

2.  Weight Loss as an Untapped Early Detection Marker in Pancreatic and Periampullary Cancer.

Authors:  Jonathan J Hue; Kavin Sugumar; Ravi K Kyasaram; John Shanahan; Joshua Lyons; Lee M Ocuin; Luke D Rothermel; Jeffrey M Hardacre; John B Ammori; Goutham Rao; Jordan M Winter; Sarah C Markt
Journal:  Ann Surg Oncol       Date:  2021-04-09       Impact factor: 5.344

Review 3.  The timing of adiposity and changes in the life course on the risk of cancer.

Authors:  Zhe Fang; Edward L Giovannucci
Journal:  Cancer Metastasis Rev       Date:  2022-07-30       Impact factor: 9.237

Review 4.  Inherited Pancreatic Cancer Syndromes and High-Risk Screening.

Authors:  Leah H Biller; Brian M Wolpin; Michael Goggins
Journal:  Surg Oncol Clin N Am       Date:  2021-07-22       Impact factor: 2.402

5.  The age-dependent association of risk factors with pancreatic cancer.

Authors:  C Yuan; J Kim; Q L Wang; A A Lee; A Babic; L T Amundadottir; A P Klein; D Li; M L McCullough; G M Petersen; H A Risch; R Z Stolzenberg-Solomon; K Perez; K Ng; E L Giovannucci; M J Stampfer; P Kraft; B M Wolpin
Journal:  Ann Oncol       Date:  2022-04-06       Impact factor: 51.769

6.  Dietary Patterns of Insulinemia, Inflammation and Glycemia, and Pancreatic Cancer Risk: Findings from the Women's Health Initiative.

Authors:  Qi Jin; Phil A Hart; Ni Shi; Joshua J Joseph; Macarius Donneyong; Darwin L Conwell; Steven K Clinton; Zobeida Cruz-Monserrate; Theodore M Brasky; Lesley F Tinker; Simin Liu; Aladdin H Shadyab; Cynthia A Thomson; Lihong Qi; Thomas Rohan; Fred K Tabung
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-04-07       Impact factor: 4.254

7.  Weight Tracking as a Novel Prognostic Marker After Pancreatectomy.

Authors:  Jonathan J Hue; Lee M Ocuin; Ravi K Kyasaram; John Shanahan; Goutham Rao; Luke D Rothermel; John B Ammori; Jeffrey M Hardacre; Jordan M Winter; Sarah C Markt
Journal:  Ann Surg Oncol       Date:  2022-01-23       Impact factor: 5.344

Review 8.  Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors.

Authors:  Alison P Klein
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-05-17       Impact factor: 73.082

9.  Identification of the Shared Gene Signatures and Biological Mechanism in Type 2 Diabetes and Pancreatic Cancer.

Authors:  Yifang Hu; Ni Zeng; Yaoqi Ge; Dan Wang; Xiaoxuan Qin; Wensong Zhang; Feng Jiang; Yun Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-31       Impact factor: 5.555

10.  CircRNF13 Promotes the Malignant Progression of Pancreatic Cancer through Targeting miR-139-5p/IGF1R Axis.

Authors:  Xinyuan Liu; Lei Zhou; Yankun Chen; Xueyi Jiang; Jianxin Jiang
Journal:  J Oncol       Date:  2021-12-03       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.